Qube Research & Technologies Ltd

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in PTCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,006,760

+$8,560,341 QoQ

Shares Held

513,823

+19.2% QoQ

Ownership

0.619%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. PTCT ranks #14 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,006,760	513,823	+19.2%	Shares	Sole	2026-05-15
2025-09-30	$26,446,419	430,934	+27.4%	Shares	Sole	2025-11-14
2025-06-30	$16,515,880	338,163	+14.0%	Shares	Sole	2025-08-14
2025-03-31	$15,113,054	296,567	+28.9%	Shares	Sole	2025-05-15
2024-12-31	$10,388,113	230,131	+171.5%	Shares	Sole	2025-02-14
2024-09-30	$3,144,187	84,749	+169.6%	Shares	Sole	2024-11-14
2024-03-31	$914,531	31,438	+200.1%	Shares	Sole	2024-05-14
2023-09-30	$234,767	10,476	-74.8%	Shares	Sole	2023-11-13
2022-09-30	$2,091,030	41,654	+218.8%	Shares	Sole	2022-11-14
2021-03-31	$618,675	13,066	+47.8%	Shares	Sole	2021-05-14
2020-12-31	$539,444	8,839	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.